Wenshuai Li1, Xiangzhu Zhu2, Yiqing Song3, Lei Fan4, Lijun Wu1, Edmond K Kabagambe2, Lifang Hou5, Martha J Shrubsole2, Jie Liu1, Qi Dai2. 1. 1Department of Digestive Diseases of Huashan Hospital,Fudan University,Shanghai 200040,People's Republic of China. 2. 2Division of Epidemiology,Department of Medicine,Vanderbilt University School of Medicine,2525 West End Avenue,Suite 800,Nashville,TN 37203-1738,USA. 3. 3Department of Epidemiology,Richard M. Fairbanks School of Public Health,Indiana University,Indianapolis,IN,USA. 4. 4Department of Oncology, Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai,People's Republic of China. 5. 5Department of Preventive Medicine,Feinberg School of Medicine,Northwestern University,Chicago,IL,USA.
Abstract
OBJECTIVE: Obesity and insulin resistance play important roles in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Mg intake is linked to a reduced risk of metabolic syndrome and insulin resistance; people with NAFLD or alcoholic liver disease are at high risk of Mg deficiency. The present study aimed to investigate whether Mg and Ca intakes were associated with risk of fatty liver disease and prediabetes by alcohol drinking status. DESIGN: We analysed the association between Ca or Mg intake and fatty liver disease, prediabetes or both prediabetes and fatty liver disease in cross-sectional analyses. SETTING: Third National Health and Nutrition Examination Survey (NHANES III) follow-up cohort of US adults. SUBJECTS: Nationally representative sample of US adults in NHANES (n 13 489). RESULTS: After adjusting for potential confounders, Mg intake was associated with approximately 30 % reduced odds of fatty liver disease and prediabetes, comparing the highest intake quartile v. the lowest. Mg intake may only be related to reduced odds of fatty liver disease and prediabetes in those whose Ca intake is less than 1200 mg/d. Mg intake may also only be associated with reduced odds of fatty liver disease among alcohol drinkers. CONCLUSIONS: The study suggests that high intake of Mg may be associated with reduced risks of fatty liver disease and prediabetes. Further large studies, particularly prospective cohort studies, are warranted to confirm the findings.
OBJECTIVE:Obesity and insulin resistance play important roles in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Mg intake is linked to a reduced risk of metabolic syndrome and insulin resistance; people with NAFLD or alcoholic liver disease are at high risk of Mg deficiency. The present study aimed to investigate whether Mg and Ca intakes were associated with risk of fatty liver disease and prediabetes by alcohol drinking status. DESIGN: We analysed the association between Ca or Mg intake and fatty liver disease, prediabetes or both prediabetes and fatty liver disease in cross-sectional analyses. SETTING: Third National Health and Nutrition Examination Survey (NHANES III) follow-up cohort of US adults. SUBJECTS: Nationally representative sample of US adults in NHANES (n 13 489). RESULTS: After adjusting for potential confounders, Mg intake was associated with approximately 30 % reduced odds of fatty liver disease and prediabetes, comparing the highest intake quartile v. the lowest. Mg intake may only be related to reduced odds of fatty liver disease and prediabetes in those whose Ca intake is less than 1200 mg/d. Mg intake may also only be associated with reduced odds of fatty liver disease among alcohol drinkers. CONCLUSIONS: The study suggests that high intake of Mg may be associated with reduced risks of fatty liver disease and prediabetes. Further large studies, particularly prospective cohort studies, are warranted to confirm the findings.
Authors: G Marchesini; M Brizi; G Bianchi; S Tomassetti; E Bugianesi; M Lenzi; A J McCullough; S Natale; G Forlani; N Melchionda Journal: Diabetes Date: 2001-08 Impact factor: 9.461
Authors: Adela Hruby; James B Meigs; Christopher J O'Donnell; Paul F Jacques; Nicola M McKeown Journal: Diabetes Care Date: 2013-10-02 Impact factor: 19.112
Authors: Jule Filler; Ricarda von Krüchten; Nina Wawro; Lisa Maier; Roberto Lorbeer; Johanna Nattenmüller; Barbara Thorand; Fabian Bamberg; Annette Peters; Christopher L Schlett; Jakob Linseisen; Susanne Rospleszcz Journal: Nutrients Date: 2021-12-28 Impact factor: 5.717